scorecardresearch

India’ Sun Pharma, Ranbaxy gain after regulator approves deal

Sun Pharmaceutical Industries gains 2.9 pct, Ranbaxy Laboratories up 3.7 pct.

Sun Pharmaceutical Industries gains 2.9 pct, Ranbaxy Laboratories up 3.7 pct.

India’s antitrust regulator approved Sun Pharma’s $3.2 bln bid to buy Ranbaxy.

Approval to speed up the merger process – Traders.

Only key approval pending now is of US Federal Trade Commission, which will come in due course of time – Analysts.

Get live Share Market updates and latest India News and business news on Financial Express. Download Financial Express App for latest business news.